Jason Adair
Corporate Officer/Principal presso Liquidia Technologies, Inc.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Jason Adair's current job is Vice President-Corporate Development & Strategy at Liquidia Technologies, Inc. He started this position in 2016.
Mr. Adair's former job was Executive Director-Corporate Development at BioCryst Pharmaceuticals, Inc. He held this position from 2011 to 2015.
He also worked as Vice President-Corporate Development & Strategy at Liquidia Corp.Mr. Adair's education includes an undergraduate degree from Wake Forest University and an MBA from Tuck School of Business at Dartmouth.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
LIQUIDIA CORPORATION
0.15% | 12/04/2024 | 111 537 ( 0.15% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Jason Adair
Società | Posizione | Inizio |
---|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 14/01/2016 |
Precedenti posizioni note di Jason Adair
Società | Posizione | Fine |
---|---|---|
BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2015 |
LIQUIDIA CORPORATION | Investor Relations Contact | - |
Formazione di Jason Adair
Wake Forest University | Undergraduate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
LIQUIDIA CORPORATION | Health Technology |
Aziende private | 1 |
---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
- Borsa valori
- Insiders
- Jason Adair